chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got my vaccine on 12/30/2020 @  14pm, on 12/31/ just had pain in my right arm. But on Fri 01/01 I woke up with severe HA ( I have migraine HA, so have tolerability for pain) and had pain in my neck and hands(like arthritic kind of pain). This HA was Migraine like but on both sides of my head and in both eyes. Regular migraine meds didn't help. HA lasted for 3 days. I was ready to go to ER but started feeling better and by the middle of the day HA was gone. I signed myself for 2nd vaccine on 1/27/21, but would like to check before I do it.
I received dose 1 pfeizer 12/21/20, dose 2 pfeizer 1/11/21 and months after several people in my life (family and coworkers) said they noticed I was hard of hearing. Joking with me that I was deaf. I told my PCP at my 40 year check up that I felt I was having trouble hearing people. She ordered a hearing test and with healthcare being so busy I didn?t get it done until this past March. I have permanent moderate to severe hearing loss in only  one ear, my right ear. I had an MRI which ruled out a brain tumor. I am getting fitted for a hearing aid in June. I have no comorbidities.  Also I was forced to get the covid booster this past February 2022 (month after having omicron) and now I have tinnitus 24/7 in the same right ear.
complained of lips tingling; observed additional 15 minutes; still had some tingling in lips but no other reactions.
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patient was vaccinated with her first dose of GARDASIL 9 and her second dose of GARDASIL 9, following the recommended vaccination schedule (dose, route of administration, lot # and expiration date were not reported for both doses). Then, one week after the second dose, she received her third dose of GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported) (inappropriate schedule of vaccine administered). There was no adverse effect reported. Additional information has been requested.
patient who got his first dose of Shingrix in 2018 and never completed the series; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (first dose of shingrix received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: patient who got his first dose of Shingrix in 2018 and never completed the series). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 03-NOV-2023 The pharmacy intern reported that a patient never completed the series.  The patient now requesting to finish the series. The Vaccine Administration Facility was the same as Primary Reporter. Chat abruptly disconnected, on callback to  reporter, she had no other patient details. Follow-up was ok to any pharmacist at the pharmacy address in health care professional details. The reporter consented to follow up. Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination.
The patient vomited all over the floor during the 15 minute observation time. Pt has a phobia of shots and needles. The patient was then escorted to the restroom. Afterwards, pt stated he was fine.
patient reported that exactly 24 hours after receiving the Pfizer covalent booster on 11-9-22, she developed severe vertigo that has not subsided since.  She reports she has always has the moderna covid vaccines, and this is her first Pfizer covid vaccine.
Pt developed dizziness, and weakness shortly after vaccination. He notes that he had significant anxiety prior to the vaccination. No respiratory issues or airway issues reported. No skin involvement reported or GI symptoms. Pt was noted to be pale. BP 78/50, HR 77, SP02 93%. BP and SP02 improved to 90/72 and 97%. Pt improved without intervention. EMS was offered but pt elected to drive home. He was encouraged to call for a ride but he declined and stated that he felt well enough to drive.
hearing loss; Information has been received regarding a case in litigation from a lawyer and the pt on 18-NOV-2020, referring to a patient (pt) of unknown age and gender. The pt's medical history, concurrent conditions and concomitant medication use were not provided. On an unknown date in 2012, the pt was vaccinated by a pharmacist in a pharmacy with zoster vaccine live (ZOSTAVAX) (lot# and route unknown) for long-term prevention of shingles and zoster-related conditions. The pt suffered the following injuries as a result of the zoster vaccine live (ZOSTAVAX) vaccine: hearing loss (deafness), therefore, the pt was hospitalized and recived treatment. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX) vaccine, the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of hearing loss was unknown. The causality assessment between hearing loss with zoster vaccine live (ZOSTAVAX) was reported as related.  Upon internal review, deafness was determined to be a medically significant event.
This is a spontaneous report from a contactable nurse. This nurse reported similar events for six patients. This is the second of six reports. A male patient (age unknown) received a dose of PREVNAR13 on an unknown date. Relevant medical history was unknown. Relevant concomitant medications included hepatitis B on an unknown date. On an unknown date, the patient experienced irritability and inconsolable crying. Relevant laboratory data were unknown. Therapeutic measures taken in response to event were unknown. The patient recovered from the events on an unknown date after three to four days. Follow-up (06JUN2011): This is a follow-up spontaneous report from the same contactable nurse. The nurse reported that she had only reported on one patient, but had receive five letters, for the same patient, in error. As a result, five cases were erroneously created regarding the same patient. There is actually only one patient and one valid case (201111773).
Clinic called to report pt was taken to ER and was diagnosed with generalized urticaria post vaccine. Was treated with Benadryl 10.9 mg PO now and q 4-6 hrs prn hives. Pt to follow up per Dr.
pt recvd vax;devel swelling of arm extending to the shoulder & the neck;this adverse event reported to hlth dept;
patient was administered an improperly stored dose of MMRII; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions and concomitant medications were not reported.    On 05-MAR-2020, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (albumin status rHA)(Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (dose, frequency and route were not provided; Lot number reported as S006048  has been verified to be valid; expiration date reported and validated as 27-FEB-2021) for prophylaxis. The vaccine was reconstituted using a properly stored sterile diluent (MERCK STERILE DILUENT).    The vaccine underwent a temperature excursion of 47.3 Fahrenheit (° F) for a period of 14 minutes. The vaccine did not underwent a previous temperature excursion. The excursion was called by a digital data logger.
1AM pt irritable, no nursing well, felt warm to touch;10AM seen in office, t101 R, irritable;had negative sepsis w/u, observed on Rocephin until cult neg;
lt upper arm began swelling the noc of the vax w/redness & pain; 1NOV92 there was a lump as large as a ping pong ball-redness & pain present;
08/30/22 presents to ED for "fevers, generalized weakness". PMHx of "HFpEF, CAD, HTN, HLD, GERD, hypothyroidism, MDD"
Patient has had an IUD placed for about 13 months and has not had a period in over a year.  Starting on 10/1 around 7:00pm, about 6-7 hours after vaccination, they began to experience abdominal cramps, then around 10:00pm, they experienced vaginal bleeding which has not stopped yet after 4 days.
A report was received from a health care professional on 12 November 2003, concerning an unknown number of vaccinees under 4 years of age who have inadvertently received Fluvirin on an unspecified date. On an unspecified date, an unspecified number of vaccinees under 4 years of age inadvertently received Fluvirin. No information was available at the time of reporting regarding the exhibition of adverse symptoms by the vaccinees. There was insufficient information to determine the reporter's causality assessment. Follow up received on 05 July 2004 confirming 10 children under the age of 4 years of age had been inadvertently administered Fluvirin instead of the product approved for pediatric use in the USA. This case involves a 22 month old female who inadvertently received Fluvirin on 04/Nov/2003. The vaccinee did not experience any adverse effects. No further information is expected. X-ref: CVOX200400231 to 00239.
#2 Hepatitis B vaccine received on 4/5/2004. 4/7/2004 reported insomnia-general malaise. 4/9/2004 nauseated, vomiting, dizziness
Expected arm is going to hurt like after first dose where she couldn't elevate her arm.; terrible headache; Felt weird.; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 08Feb2021 (Lot number: EL9264) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "an accident three to four years ago on her left arm" (unspecified if ongoing), notes: three to four years ago.; "achy and felt the pain" (unspecified if ongoing), notes: three to four years ago.; "it is like the flu" (unspecified if ongoing), notes: three to four years ago.; "She has a plate in the left arm" (unspecified if ongoing), notes: three to four years ago. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "Expected arm is going to hurt like after first dose where she couldn't elevate her arm."; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "terrible headache"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "Felt weird.". The events "expected arm is going to hurt like after first dose where she couldn't elevate her arm.", "terrible headache" and "felt weird." were evaluated at the physician office visit. Additional Information: The patient had an accident three to four years ago on her left arm. She was left-handed. Pain there was horrible form the beginning. From her accident she doesn't take therapy or nothing. She was ok. She stated it was like the flu. She started getting achy and felt the pain. From the accident everything was ok. She was feeling it all over her body. She has a plate in the left arm. The patient has no additional vaccines administered on the same date of vaccine. The patient has not received any vaccine within 4 weeks prior to vaccination. The patient has no family medical history. The patient expected arm was going to hurt like after first dose where she couldn't elevate her arm. She had terrible (headache) off and on since first COVID Vaccine and felt weird. The events required a visit to physician's office. She did not visit emergency room. The patient received second dose COVID vaccine on 01Mar2021.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021264901 same patient/reporter/drug, different AE in separated time
This spontaneous report was received from a registered nurse who reported that 9 patients received VAQTA (lot number not reported) exposed to minus 1 degree C for 3.5 days (84 hours), an excursion that was unsupported by in-house stability data. No adverse symptoms reported. Nurse stated these patients received the product in question between 03-MAR-2014 and 04-MAR-2014. This is one of two reports from the same reporter source (linked MARRS# 1403USA003463). Additional information has been requested.
On March 8th, my hair on the right side and back of my head turned to straw. It was virtually impossible to get a brush through it. On  March 11th, I had chills and a headache. This lasted for about 6  hours.
abundance of gas; extra bowel movements; experienced aching on the injection site; diarrhea; felt tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 89 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) at the age of 89 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Irritable bowel syndrome" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FLATULENCE (non-serious), outcome "unknown", described as "abundance of gas"; BOWEL MOVEMENT IRREGULARITY (non-serious), outcome "unknown", described as "extra bowel movements"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "experienced aching on the injection site"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; FATIGUE (non-serious), outcome "unknown", described as "felt tired".  Additional information: Caller mentioned she has a "very sensitive gut" and reported to have experienced an "abundance of gas & a couple of extra bowel movements" after the vaccination. Caller also mentioned that she is unsure if this would be due to the vaccine since she also started a "special vitamin" which may have caused this also. Had her 1st dose of Covid 19 Vaccine (03Mar2021), experienced aching on the injection site and felt tired. Caller has IBS (Irritable bowel syndrome) wants to know more information if this vaccine has something to do with gas bloating, diarrhea or frequent bowel movement.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recvd vax;sometime p/ 1st dose had elev liver func test & hematomegaly;seen by MD
At 11am the morning after (10/22) the pneumonia vaccine I had a complete lack of appetite and an increasing fever. Shortly after that I started to have deep full body muscle aches, chills and my right arm pain/redness/swelling was intensifying. By 6pm that day my fever was 102.6 and I started to vomit uncontrollably. I knew something was very wrong and went to Urgent Care. Between my fever, high pulse rate and elevated WBC count they sent me to the ER with what they perceived to be an infection. The ER got me in right away and were hesitant to diagnose an infection so quickly and indicated my immune system might just be having a strong reaction to the vaccine. They wanted me to keep an eye on the injection site and if it got worse I could start taking antibiotics but they warned me not to panic and often times it could look worse the next day. The next morning all my symptoms escalated/returned even worse than before and I had to be rushed back to the ER. This time I was diagnosed with Cellulitis and given IV antibiotics and a full work up of tests. After 7-10 days on 2 different antibiotics all my symptoms cleared up.
Severe headache and body aches. Lasted for 3 days. Gave ibuprofen and lots of rest.
small knot in his neck; arm was a little sore; severe neck pain; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (small knot in his neck), PAIN IN EXTREMITY (arm was a little sore) and NECK PAIN (severe neck pain) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.  The patient's past medical history included No adverse event (No medical reported history).   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was a little sore) and NECK PAIN (severe neck pain). On 10-Feb-2021, the patient experienced LYMPHADENOPATHY (small knot in his neck). At the time of the report, LYMPHADENOPATHY (small knot in his neck), PAIN IN EXTREMITY (arm was a little sore) and NECK PAIN (severe neck pain) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    The patient's concomitant medications were not provided.  On 08 Feb 2021, The patient's arm was a little sore that evening and moved up to the left side of his neck which was in severe pain.  On 10 Feb 2021, The patient's wife could feel a small knot in his neck at the time of the report. He had used heat and ice.Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient received vaccine on 1/15/21. Patient felt heavy pressure of chest within 15-20 mins later.  On 1/16/21 and 1/17/21, patient felt fatigue, nausea, and headache.  On Friday 1/22/21, arm felt funny and when taking off blouse, noticed rash at site of injection and was throbbing.  On Sat 1/23/21, patient had a harder time clearing throat.  She gradually started feeling throat closing, was in the ER around 4pm that day.  Face was swollen and red and tingling up and down whole body.  Patient was given benadryl, famotidine, and methylpredinisolone via IV.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 35-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Alcohol use (3 drinks/week). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (UNISOM [DIPHENHYDRAMINE HYDROCHLORIDE]) for Morning sickness, VITAMIN B6 for Nausea, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 16-Nov-2020 and the estimated date of delivery was 28-Aug-2021. On 26-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Dec-2020, Pregnancy test: Positive. On 07-Jan-2021, Ultrasound foetal: normal. On 28-Jan-2021, Amniocentesis: normal normal. On 28-Jan-2021, Ultrasound foetal: normal. On 18-Feb-2021, Amniocentesis: no results yet.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Information has been received from an immunization official concerning a 12 month old pt who was vaccinated with a dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3)  that may not have been stored as recommended. It was reported that several weeks post vaccination the pt developed an atypical measles like rash and was seen at a local ER and released. The pt was treated with an unspecified prescription medication. The outcome of the pt's measle like rash was unknown. Additional information has been requested.
4th DPT on 3/17/08 within 24 hr upper thigh 2x size and 8 x 10 cm induration, tenderness.
Red, swollen, hard and warm at injection site days 1-3 after vaccine. Went away day 4. Day 7 came back more intense redness, itching, rock hard and swollen, and is spreading.
muscle pain; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2019, the patient received Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was recovering/resolving.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional details were received as follows: The case was reported via chat. The age at vaccination was not reported, but it could be 64 or 65 years. The patient after vaccination experienced muscle pain. The event was ongoing.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/ allergies were not reported. On 28-MAR-2019, the patient was vaccinated with one dose of improperly stored VARIVAX (lot # R018780, expiry date: 01-JUL-2020) for prophylaxis (dosing details, dose number, route not reported) (product storage error). The vaccine underwent temperature excursion from -14 degree Celsius to -10 degree Celsius (- 12.5 degree Celsius) for a time frame of 2 hours 15 minutes. There was a previous temperature excursion which was between - 9 degree Celsius to 8 degree Celsius (- 5.1 degree Celsius) for 1 hour 15 minutes. Digital data logger was involved. No adverse effects were reported. No product quality complaint (PQC) identified. This is one of several reports received from the same reporter.
Cluster of 3 patients (individual patient identification provided) experienced injection site reaction with Decavac (lot number U1587BA) received from a nurse in the USA on 16 November 2006. A 56 year old female patient developed a large lump, hot, red, itchy after she received an injection of Decavac (lot number U1587BA (corrected), route of administration not reported) in the left arm on 03 November 2006. She also had nauses and a temperature of 99 (degrees). At the time of vaccination, she had osteoarthritis, hypothyroid and pancreatitis. The patient recovered. This case has the same reporter as cases 2006-03126, 2006-03127, 2006-03129. Corrective new version was created on 22 November 2006. No additional information was received. Follow-up information received on 05 March 2007 from a health care professional. Decavac was administered intramuscularly on 03 November 2006.
I have been having muscle ache at the injection site since the day I got my 2nd dose vaccine.. It's very hurt when I move my arm or lift up.. It's very painful.
I was 8 weeks pregnant when I had a miscarriage on September 7th.  Estimated due date was April 22.  This was my second pregnancy.  1st pregnancy had no complications during pregnancy and birth, had a healthy baby boy on July 23, 2020.